Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Enterobacteriaceae | 6 | 2019 | 395 | 2.25 | Why? |
| Carbapenem-Resistant Enterobacteriaceae | 4 | 2021 | 214 | 1.57 | Why? |
| Carbapenems | 4 | 2017 | 343 | 1.33 | Why? |
| Azabicyclo Compounds | 2 | 2018 | 91 | 1.33 | Why? |
| beta-Lactamases | 5 | 2021 | 759 | 1.22 | Why? |
| Klebsiella pneumoniae | 5 | 2018 | 658 | 1.15 | Why? |
| Klebsiella Infections | 3 | 2018 | 466 | 1.05 | Why? |
| Enterobacteriaceae Infections | 2 | 2021 | 529 | 1.02 | Why? |
| Penicillanic Acid | 3 | 2017 | 58 | 1.01 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 5 | 2020 | 711 | 0.96 | Why? |
| Piperacillin | 3 | 2017 | 63 | 0.92 | Why? |
| Drug Resistance, Multiple, Bacterial | 3 | 2018 | 1115 | 0.87 | Why? |
| Bacterial Proteins | 6 | 2021 | 1318 | 0.83 | Why? |
| Anti-Bacterial Agents | 12 | 2021 | 10083 | 0.74 | Why? |
| Trophoblasts | 1 | 2020 | 237 | 0.73 | Why? |
| Imipenem | 1 | 2018 | 57 | 0.73 | Why? |
| Bacteremia | 6 | 2021 | 1372 | 0.66 | Why? |
| Ceftazidime | 1 | 2018 | 134 | 0.64 | Why? |
| beta-Lactam Resistance | 1 | 2018 | 150 | 0.64 | Why? |
| Staphylococcal Infections | 5 | 2020 | 1099 | 0.63 | Why? |
| Cephalosporins | 1 | 2017 | 250 | 0.58 | Why? |
| Staphylococcus aureus | 2 | 2020 | 844 | 0.55 | Why? |
| Vancomycin | 1 | 2017 | 328 | 0.54 | Why? |
| Rectum | 1 | 2017 | 495 | 0.53 | Why? |
| Bacteria | 3 | 2019 | 1897 | 0.52 | Why? |
| Placenta | 2 | 2020 | 1531 | 0.51 | Why? |
| Microbial Sensitivity Tests | 7 | 2019 | 2886 | 0.37 | Why? |
| Carrier State | 1 | 2018 | 2100 | 0.31 | Why? |
| Colistin | 2 | 2019 | 217 | 0.31 | Why? |
| Plasmids | 3 | 2019 | 840 | 0.30 | Why? |
| Genetic Variation | 1 | 2018 | 3919 | 0.27 | Why? |
| Evolution, Molecular | 1 | 2017 | 3691 | 0.25 | Why? |
| Liver Transplantation | 1 | 2018 | 2864 | 0.24 | Why? |
| Intracranial Hemorrhages | 2 | 2021 | 1170 | 0.24 | Why? |
| Phagocytosis | 2 | 2021 | 409 | 0.23 | Why? |
| Hypoxia-Ischemia, Brain | 1 | 2021 | 86 | 0.22 | Why? |
| Brain Stem Infarctions | 1 | 2020 | 26 | 0.21 | Why? |
| Thalamus | 1 | 2020 | 75 | 0.21 | Why? |
| Microglia | 2 | 2021 | 357 | 0.21 | Why? |
| Agar | 1 | 2019 | 15 | 0.21 | Why? |
| Brain Infarction | 1 | 2021 | 129 | 0.21 | Why? |
| Disk Diffusion Antimicrobial Tests | 1 | 2019 | 36 | 0.21 | Why? |
| Cerebellar Diseases | 1 | 2020 | 90 | 0.20 | Why? |
| In Situ Hybridization | 1 | 2020 | 390 | 0.19 | Why? |
| Clonal Evolution | 1 | 2018 | 55 | 0.18 | Why? |
| Barrett Esophagus | 1 | 2019 | 68 | 0.18 | Why? |
| Precancerous Conditions | 1 | 2019 | 108 | 0.18 | Why? |
| Keratin-1 | 1 | 2017 | 1 | 0.18 | Why? |
| Keratin-10 | 1 | 2017 | 2 | 0.18 | Why? |
| New York City | 3 | 2021 | 7432 | 0.18 | Why? |
| Bacterial Load | 1 | 2018 | 179 | 0.18 | Why? |
| Serratia marcescens | 1 | 2017 | 38 | 0.17 | Why? |
| Bacterial Adhesion | 1 | 2017 | 69 | 0.17 | Why? |
| Virulence Factors | 2 | 2018 | 338 | 0.17 | Why? |
| Neurons | 2 | 2021 | 864 | 0.17 | Why? |
| Staphylococcus epidermidis | 1 | 2017 | 53 | 0.17 | Why? |
| Vancomycin-Resistant Enterococci | 1 | 2018 | 104 | 0.17 | Why? |
| Community-Acquired Infections | 2 | 2021 | 2328 | 0.17 | Why? |
| Phylogeography | 1 | 2021 | 824 | 0.17 | Why? |
| Bacterial Infections | 2 | 2021 | 2229 | 0.17 | Why? |
| beta-Lactamase Inhibitors | 1 | 2017 | 104 | 0.16 | Why? |
| Drug Resistance, Fungal | 1 | 2018 | 191 | 0.16 | Why? |
| Plasmodium falciparum | 3 | 2010 | 337 | 0.16 | Why? |
| Membrane Transport Proteins | 1 | 2017 | 152 | 0.15 | Why? |
| Phenotype | 2 | 2017 | 4037 | 0.15 | Why? |
| Genomics | 2 | 2018 | 3118 | 0.15 | Why? |
| Cross Infection | 4 | 2018 | 8675 | 0.15 | Why? |
| Artemisinins | 2 | 2010 | 238 | 0.15 | Why? |
| Genotype | 2 | 2017 | 4697 | 0.14 | Why? |
| Point Mutation | 1 | 2018 | 481 | 0.14 | Why? |
| Serogroup | 1 | 2017 | 510 | 0.14 | Why? |
| Molecular Epidemiology | 2 | 2017 | 1638 | 0.14 | Why? |
| Esophageal Neoplasms | 1 | 2019 | 357 | 0.13 | Why? |
| Phylogeny | 3 | 2021 | 13341 | 0.13 | Why? |
| New York | 1 | 2021 | 2488 | 0.13 | Why? |
| Cohort Studies | 4 | 2021 | 36005 | 0.12 | Why? |
| Hospitals, Teaching | 1 | 2021 | 1609 | 0.12 | Why? |
| Clinical Laboratory Services | 1 | 2019 | 781 | 0.12 | Why? |
| Adenocarcinoma | 1 | 2019 | 651 | 0.12 | Why? |
| Virulence | 1 | 2019 | 2172 | 0.11 | Why? |
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2010 | 16 | 0.11 | Why? |
| Sentinel Surveillance | 1 | 2018 | 1093 | 0.11 | Why? |
| Mutation | 3 | 2021 | 12376 | 0.10 | Why? |
| Pancreatitis | 1 | 2018 | 688 | 0.10 | Why? |
| Humans | 28 | 2021 | 930598 | 0.10 | Why? |
| Microbiota | 1 | 2019 | 1240 | 0.09 | Why? |
| Aged | 11 | 2021 | 215776 | 0.09 | Why? |
| Brain Diseases | 1 | 2020 | 1463 | 0.09 | Why? |
| Male | 15 | 2021 | 367725 | 0.09 | Why? |
| Drug Combinations | 1 | 2018 | 3852 | 0.09 | Why? |
| Drug Resistance, Bacterial | 1 | 2017 | 1414 | 0.09 | Why? |
| Whole Genome Sequencing | 1 | 2018 | 3239 | 0.08 | Why? |
| Gene Expression | 1 | 2018 | 3332 | 0.08 | Why? |
| Shock, Septic | 1 | 2017 | 1313 | 0.08 | Why? |
| Parasitemia | 1 | 2006 | 88 | 0.08 | Why? |
| Clindamycin | 1 | 2006 | 59 | 0.08 | Why? |
| Female | 13 | 2021 | 380317 | 0.08 | Why? |
| Malaria, Falciparum | 2 | 2010 | 377 | 0.08 | Why? |
| Retrospective Studies | 5 | 2021 | 105322 | 0.08 | Why? |
| Organ Transplantation | 1 | 2021 | 2616 | 0.08 | Why? |
| Middle Aged | 11 | 2021 | 270681 | 0.07 | Why? |
| Transplant Recipients | 2 | 2021 | 4982 | 0.07 | Why? |
| Antimalarials | 2 | 2010 | 2505 | 0.07 | Why? |
| Gastrointestinal Microbiome | 1 | 2018 | 1961 | 0.07 | Why? |
| Liver Diseases | 1 | 2020 | 2698 | 0.07 | Why? |
| Feces | 1 | 2018 | 4235 | 0.07 | Why? |
| Brain | 1 | 2021 | 5133 | 0.07 | Why? |
| Critical Illness | 2 | 2017 | 17281 | 0.06 | Why? |
| Gastrointestinal Diseases | 1 | 2018 | 2580 | 0.06 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.06 | Why? |
| Drug Resistance | 1 | 2004 | 395 | 0.06 | Why? |
| Olivary Nucleus | 1 | 2020 | 18 | 0.06 | Why? |
| Pontine Tegmentum | 1 | 2020 | 18 | 0.06 | Why? |
| Cerebellar Nuclei | 1 | 2020 | 22 | 0.06 | Why? |
| Pregnancy | 2 | 2020 | 23879 | 0.06 | Why? |
| Adult | 7 | 2021 | 244371 | 0.05 | Why? |
| Medulla Oblongata | 1 | 2020 | 40 | 0.05 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.05 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2020 | 6653 | 0.05 | Why? |
| Acinetobacter | 1 | 2019 | 58 | 0.05 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.05 | Why? |
| Mupirocin | 1 | 2019 | 22 | 0.05 | Why? |
| Pregnancy Trimester, Second | 1 | 2020 | 314 | 0.05 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.05 | Why? |
| Prospective Studies | 3 | 2018 | 43301 | 0.05 | Why? |
| Case-Control Studies | 1 | 2017 | 17671 | 0.04 | Why? |
| Lactococcus lactis | 1 | 2017 | 45 | 0.04 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.04 | Why? |
| Enterobacter | 1 | 2017 | 18 | 0.04 | Why? |
| Chlorhexidine | 1 | 2019 | 176 | 0.04 | Why? |
| Microscopy, Atomic Force | 1 | 2017 | 118 | 0.04 | Why? |
| Animals | 6 | 2019 | 78931 | 0.04 | Why? |
| Survival Rate | 2 | 2021 | 9206 | 0.04 | Why? |
| Keratinocytes | 1 | 2017 | 119 | 0.04 | Why? |
| Host-Pathogen Interactions | 1 | 2017 | 11041 | 0.04 | Why? |
| Africa, Northern | 1 | 2018 | 539 | 0.04 | Why? |
| RNA, Viral | 2 | 2021 | 32276 | 0.04 | Why? |
| Obesity | 1 | 2017 | 7388 | 0.04 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.04 | Why? |
| Stillbirth | 1 | 2020 | 544 | 0.04 | Why? |
| Disease-Free Survival | 1 | 2021 | 1654 | 0.04 | Why? |
| Inhibitory Concentration 50 | 2 | 2010 | 907 | 0.04 | Why? |
| Genome, Bacterial | 1 | 2019 | 446 | 0.04 | Why? |
| Biofilms | 1 | 2018 | 304 | 0.04 | Why? |
| Intensive Care Units | 2 | 2021 | 29594 | 0.04 | Why? |
| Pregnancy Complications, Infectious | 1 | 2020 | 11559 | 0.03 | Why? |
| Pseudomonas aeruginosa | 1 | 2019 | 652 | 0.03 | Why? |
| Monte Carlo Method | 1 | 2017 | 577 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.03 | Why? |
| United States | 1 | 2021 | 46150 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 2 | 2017 | 3776 | 0.03 | Why? |
| North America | 1 | 2018 | 1400 | 0.03 | Why? |
| Middle East | 1 | 2018 | 1418 | 0.03 | Why? |
| Infusions, Intravenous | 1 | 2017 | 1224 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2021 | 27595 | 0.03 | Why? |
| Phosphoproteins | 1 | 2021 | 4346 | 0.03 | Why? |
| Nose | 1 | 2017 | 1093 | 0.03 | Why? |
| Headache | 1 | 2020 | 2257 | 0.02 | Why? |
| Heart Arrest | 1 | 2020 | 1239 | 0.02 | Why? |
| Escherichia coli | 1 | 2017 | 1547 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Membrane Proteins | 1 | 2017 | 1733 | 0.02 | Why? |
| Antigens, Protozoan | 1 | 2006 | 121 | 0.02 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2021 | 13720 | 0.02 | Why? |
| Venous Thrombosis | 1 | 2021 | 2739 | 0.02 | Why? |
| Protozoan Proteins | 1 | 2006 | 205 | 0.02 | Why? |
| Hypoxia | 1 | 2020 | 3626 | 0.02 | Why? |
| Epithelial Cells | 1 | 2017 | 3508 | 0.02 | Why? |
| Renal Dialysis | 1 | 2021 | 4358 | 0.02 | Why? |
| T-Lymphocytes | 1 | 2021 | 6670 | 0.02 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2019 | 11304 | 0.02 | Why? |
| Pulmonary Embolism | 1 | 2021 | 4775 | 0.01 | Why? |
| Acute Kidney Injury | 1 | 2021 | 5762 | 0.01 | Why? |
| Europe | 1 | 2018 | 12702 | 0.01 | Why? |
| Coinfection | 1 | 2021 | 6820 | 0.01 | Why? |
| Protein Binding | 1 | 2017 | 11430 | 0.01 | Why? |
| Disease Progression | 1 | 2019 | 13580 | 0.01 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.01 | Why? |
| Regression Analysis | 1 | 2006 | 2484 | 0.01 | Why? |
| Mice | 1 | 2019 | 21357 | 0.01 | Why? |
| Inflammation | 1 | 2021 | 13255 | 0.01 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.01 | Why? |
| Prognosis | 1 | 2019 | 32490 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.01 | Why? |
| Critical Care | 1 | 2018 | 14081 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.01 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.01 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 7868 | 0.01 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
| Child | 1 | 2019 | 70012 | 0.01 | Why? |
| Risk Factors | 1 | 2018 | 71621 | 0.01 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.01 | Why? |